Do you think Creativ processed our large batch of Hiv blood, that was retained for 5 yrs
Ive always thought maybe why have not yet had the 1600 patient report ?
Actually, Creatv could process all past 1600.
Of course that would have started some time ago.
Literally just now looked @ Creatv for an answer:
Yes, Creatv Bio's LifeTracDx® technology can process retained or stored blood samples for liquid biopsy analysis.
PubMed Central (PMC) (.gov)
+1
Key details regarding the processing of retained samples with LifeTracDx:
Viability Preservation:
The technology uses a proprietary Sample Transportation Solution (SBTS) that allows patient blood samples containing live Circulating Tumor Cells (CTCs) to be stored or transported for up to 6 days at room temperature while maintaining cell viability.
Sample Types:
LifeTracDx focuses on isolating Cancer Associated Macrophage-Like cells (CAMLs) and CTCs from whole blood.
Applications:
These retained samples can be used for various analyses, including monitoring PD-L1 expression, tracking treatment response, and genomic sequencing of tumor DNA.
Ive always thought maybe why have not yet had the 1600 patient report ?
Actually, Creatv could process all past 1600.
Of course that would have started some time ago.
Literally just now looked @ Creatv for an answer:
Yes, Creatv Bio's LifeTracDx® technology can process retained or stored blood samples for liquid biopsy analysis.
PubMed Central (PMC) (.gov)
+1
Key details regarding the processing of retained samples with LifeTracDx:
Viability Preservation:
The technology uses a proprietary Sample Transportation Solution (SBTS) that allows patient blood samples containing live Circulating Tumor Cells (CTCs) to be stored or transported for up to 6 days at room temperature while maintaining cell viability.
Sample Types:
LifeTracDx focuses on isolating Cancer Associated Macrophage-Like cells (CAMLs) and CTCs from whole blood.
Applications:
These retained samples can be used for various analyses, including monitoring PD-L1 expression, tracking treatment response, and genomic sequencing of tumor DNA.
4